Cosmo Pharmaceuticals N.V.
General ticker "CMOPF" information:
- Sector: Health Care
- Industry: Drug Manufacturers - General
- Capitalization: $1.1B (TTM average)
Cosmo Pharmaceuticals N.V. follows the US Stock Market performance with the rate: 39.7%.
Estimated limits based on current volatility of 3.5%: low 108.08$, high 115.84$
Factors to consider:
- Company pays dividends (annually): last record date 2025-06-05, amount 2.40$ (Y2.22%)
Short-term CMOPF quotes
Long-term CMOPF plot
Financial data
| YTD | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Operating Revenue | €266.79MM | €104.82MM |
| Operating Expenses | €117.91MM | €115.30MM |
| Operating Income | €148.88MM | €-10.48MM |
| Non-Operating Income | €4.49MM | €9.56MM |
| Interest Expense | €0.13MM | €0.18MM |
| R&D Expense | €0.37MM | €32.29MM |
| Income(Loss) | €153.37MM | €-0.92MM |
| Taxes | €20.18MM | €2.59MM |
| Profit(Loss)* | €133.24MM | €-3.63MM |
| Stockholders Equity | €498.33MM | €481.78MM |
| Inventory | €13.51MM | €10.42MM |
| Assets | €646.77MM | €611.97MM |
| Operating Cash Flow | €162.41MM | €-11.61MM |
| Capital expenditure | €5.65MM | €4.23MM |
| Investing Cash Flow | €-128.88MM | €49.84MM |
| Financing Cash Flow | €-40.22MM | €-24.61MM |
| Earnings Per Share** | €8.14 | €-0.23 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.